InvestSMART

Immutep Limited (ASX: IMM) - Announcements

- Current share price for IMM : $0.023

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Change in substantial holding 9 Jun 2026 8:13AM $0.048 $0.023 fallen by 52.08%
$34 Becoming a substantial holder 9 Jun 2026 8:12AM $0.048 $0.023 fallen by 52.08%
$34 Change in substantial holding 4 Jun 2026 5:30PM $0.050 $0.023 fallen by 54%
$34 Immutep Presents Positive IMP761 Phase I Data at EULAR 2026 4 Jun 2026 8:23AM $0.051 $0.023 fallen by 54.90%
$34 Change in substantial holding 29 May 2026 5:03PM $0.053 $0.023 fallen by 56.60%
$34 Efti immune activation associated with improved survival 28 May 2026 9:18AM $0.054 $0.023 fallen by 57.41%
$34 Change in substantial holding 27 May 2026 6:51PM $0.054 $0.023 fallen by 57.41%
$34 Ceasing to be a substantial holder 11 May 2026 8:16AM $0.060 $0.023 fallen by 61.67%
$34 Immutep Receives Nasdaq Notice of Bid Price Deficiency 30 Apr 2026 9:21AM $0.063 $0.023 fallen by 63.49%
$34 Immutep Quarterly Activities Report and Appendix 4C 30 Apr 2026 9:01AM $0.063 $0.023 fallen by 63.49%
$34 Change in substantial holding 27 Apr 2026 8:15AM $0.070 $0.023 fallen by 67.14%
$34 Change in substantial holding 27 Apr 2026 8:13AM $0.070 $0.023 fallen by 67.14%
$34 Change in substantial holding 23 Apr 2026 8:15AM $0.074 $0.023 fallen by 68.92%
$34 Abstract on Efti accepted for presentation at ASCO 2026 22 Apr 2026 10:05AM $0.073 $0.023 fallen by 68.49%
$34 Change in substantial holding 17 Apr 2026 8:22AM $0.075 $0.023 fallen by 69.33%
$34 Immutep receives FDA ODD for Efti in Soft Tissue Sarcoma 15 Apr 2026 9:27AM $0.039 $0.023 fallen by 41.03%
$34 Change in substantial holding 13 Apr 2026 8:17AM $0.040 $0.023 fallen by 42.50%
$34 Change in substantial holding 10 Apr 2026 8:19AM $0.041 $0.023 fallen by 43.90%
$34 Immutep Investor Update 8 Apr 2026 10:06AM $0.042 $0.023 fallen by 45.24%
$34 Change in substantial holding 20 Mar 2026 8:18AM $0.051 $0.023 fallen by 54.90%
$34 Change in substantial holding 20 Mar 2026 8:18AM $0.051 $0.023 fallen by 54.90%
$34 Ceasing to be a substantial holder from IFL 19 Mar 2026 1:24PM $0.055 $0.023 fallen by 57.80%
$34 Update on Phase I Study of IMP761 for Autoimmune Diseases 19 Mar 2026 8:20AM $0.052 $0.023 fallen by 55.77%
$34 Change in substantial holding 19 Mar 2026 8:19AM $0.052 $0.023 fallen by 55.77%
$34 Change in substantial holding 19 Mar 2026 8:16AM $0.052 $0.023 fallen by 55.77%

26 - 50 of 790 results

Page 2 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.